Table 2 Demographic and clinical characteristics of 70 women who underwent MR-HIFU treatments
Characteristics of all 70 women | Characteristics of first 22 women | Characteristics of remaining 48 women | |||
|---|---|---|---|---|---|
Age (years) median [range] 46.0 [26–57] | Age (years) median [range] 47.0 [41–57] | Age (years) median [range] 45.0 [26–54]* | |||
BMI (kg/m2) median [range] 24.3 [17.5–35.5] | BMI (kg/m2) median [range] 24.0 [20.4–31.9] | BMI (kg/m2) median [range] 24.6 [17.5–35.5] |
Characteristics of all 76 treatments | Characteristics of first 25 treatments | Characteristics of remaining 51 treatments | |||
|---|---|---|---|---|---|
Amount of fibroids treated N (%) | Amount of fibroids treated N (%) | Amount of fibroids treated N (%) | |||
1 | 61 (80.3%) | 1 | 24 (96.0%) | 1 | 37 (72.5%) |
2 | 6 (7.9%) | 2 | 1 (4.0%) | 2 | 5 (9.8%) |
3 | 6 (7.9%) | 3 | 0 | 3 | 6 (11.8%) |
4 | 2 (2.6%) | 4 | 0 | 4 | 2 (3.9%) |
5 | 1 (1.3%) | 5 | 0 | 5 | 1 (2.0%) |
Characteristics of all 102 fibroids | Characteristics of first 21 fibroids | Characteristics of remaining 81 fibroids | |||
|---|---|---|---|---|---|
Location | N (%) | Location | N (%) | Location | N (%) |
Submucosal | 27 (26.5%) | Submucosal | 6 (28.6%) | Submucosal | 21 (25.9%) |
Intramural | 26 (25.5%) | Intramural | 3 (14.3%) | Intramural | 23 (28.4%) |
Subserosal | 33 (32.4%) | Subserosal | 9 (42.9%) | Subserosal | 24 (29.6%) |
Hybrid | 16 (15.7%) | Hybrid | 3 (14.3%) | Hybrid | 13 (16.0%) |
Funaki type | N (%) | Funaki type | N (%) | Funaki type | N (%) |
1 | 10 (9.8%) | 1 | 1 (4.8%) | 1 | 9 (11.1%) |
2 | 83 (81.4%) | 2 | 19 (90.5%) | 2 | 64 (79.0%) |
3 | 9 (8.8%) | 3 | 1 (4.8%) | 3 | 8 (9.9%) |
Diameter (cm) median [range] 4.8 [1.4–18.1] | Diameter (cm) median [range] 6.0 [1.7–10.3] | Diameter (cm) median [range] 4.6 [1.4–18.1] | |||